IGF1-LR3 Vial

IGF-1 LR3 (Insulin-like Growth Factor 1, Long Arg3) is a synthetic analogue of IGF-1 modified to reduce binding affinity to IGF-binding proteins, resulting in an extended circulation profile compared to native IGF-1.

IGF-1 LR3 is a laboratory-engineered peptide designed to extend the activity profile of native IGF-1 through structural modification. In controlled research environments, it is utilised as a model compound in studies involving IGF-related pathways, peptide structure, and receptor interaction systems.

Chemical reference information: CAS number: 946870-92-4; Molecular formula: C₄₀₀H₆₂₅N₁₁₀O₁₁₅S₉; Molecular weight: 9117.6 g/mol. These reference identifiers describe the formulation; the batch-specific analytical record identifies the supplied material.

Reference conditions for unreconstituted research material are −20°C with moisture and direct light excluded. Use the storage instructions on the supplied batch record for the actual presentation, and record any change of physical state or storage conditions.

Where laboratory preparation is required, use an appropriate validated solvent and aseptic peptide-handling procedure. Solvent compatibility, final concentration, and post-preparation storage depend on the specific formulation and experimental protocol. The catalog strength is the compound amount, not the concentration of a prepared solution.

NORVEXA Bioscience batch documentation can be requested using the printed reference and lot number. Review identity, analytical purity, presentation, and handling specifications before including a material in a laboratory workflow.

IGF1-LR3 1 mg is offered as a NORVEXA research vial. The selected strength refers to the compound content of this vial reference. Request the matching batch record for identity, analytical specifications, and presentation details.

Reference conditions for unreconstituted research material are −20°C with moisture and direct light excluded. Use the storage instructions on the supplied batch record for the actual presentation, and record any change of physical state or storage conditions.

Where laboratory preparation is required, use an appropriate validated solvent and aseptic peptide-handling procedure. Solvent compatibility, final concentration, and post-preparation storage depend on the specific formulation and experimental protocol. The catalog strength is the compound amount, not the concentration of a prepared solution.

NORVEXA Bioscience batch documentation can be requested using the printed reference and lot number. Review identity, analytical purity, presentation, and handling specifications before including a material in a laboratory workflow.

CAS number

946870-92-4

Molecular formula

C₄₀₀H₆₂₅N₁₁₀O₁₁₅S₉

Molecular weight

9117.6 g/mol

Include the printed batch reference when requesting your certificate of analysis. The record applies to the batch supplied to your laboratory.